Law360, New York (February 13, 2012, 7:41 PM ET) -- President Barack Obama's proposed budget for 2013, released Monday, seeks to increase the availability of generic medications by prohibiting pay-for-delay settlements between brand-name and generic-drug makers and slashing the 12-year exclusivity period for biologics.
The president's budget proposal for the 2013 fiscal year said the two changes would generate billions in savings for federal health care programs, including Medicare and Medicaid, by facilitating access to lower-cost generic drugs and biologics.
The proposal seeks authorization for the Federal Trade Commission to stop companies from entering pay-for-delay settlements,...
Obama's 2013 Budget Targets Pay-For-Delay Deals
To view the full article, take a free trial now.
